Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-adrenergic modulation and estrogen effects on bone remodeling in early postmenopausal women
NL-OMON25589Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of estradiol, terbutaline and propranolol in osteoporosis (4 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in bone turnover markers. Started May 2011; status: active, not recruiting.
02
Drugs
estradiolterbutalinepropranolol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NL-OMON25589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25589.